CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
- Resource Type
- Article
- Authors
- Minson, Adrian; Hamad, Nada; Cheah, Chan Y.; Tam, Constantine; Blombery, Piers; Westerman, David; Ritchie, David; Morgan, Huw; Holzwart, Nicholas; Lade, Stephen; Anderson, Mary Ann; Khot, Amit; Seymour, John F.; Robertson, Molly; Caldwell, Imogen; Ryland, Georgina; Saghebi, Javad; Sabahi, Zahra; Xie, Jing; Koldej, Rachel; Dickinson, Michael
- Source
- In Blood 22 February 2024 143(8):673-684
- Subject
- Clinical Trials and Observations
Immunobiology and Immunotherapy
Lymphoid Neoplasia
- Language
- ISSN
- 0006-4971